The medical device company made $1.3 million during the fourth quarter, bringing its total revenue for 2021 up to $5.2 million. It made $4.6 million in revenue in 2020.
Smith+Nephew also highlighted several accomplishments from last year in a Feb. 22 news release, including the new growth strategies, product launches and the expansion of its robotics platform. It also included its announcement of Deepak Nath, PhD, as CEO.
The company is aiming for a 4 to 6 percent growth in underlying revenue by 2024 and a trading profit margin of at least 21 percent.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.